Skip to main content
logo
Immutep Limited (ASX:IMM)
Australia flag Australia · Delayed Price · Currency is AUD
0.0530
0.00 (0.00%)
May 29, 2026, 4:10 PM AEST

Immutep Revenue

Immutep had revenue of 4.10M AUD in the half year ending December 31, 2025, with 4,506.79% growth. This brings the company's revenue in the last twelve months to 51.77K, down -2.90% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 59.71K, down -49.86%.

Revenue (ttm)
51.77K
Revenue Growth
-2.90%
P/S Ratio
9.86
Revenue / Employee
255.57K
Employees
31
Market Cap
78.11M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202559.71K-59.38K-49.86%
Jun 30, 2024119.09K-72.63K-37.88%
Jun 30, 2023191.72K-62.67K-24.63%
Jun 30, 2022254.39K-58.45K-18.68%
Jun 30, 2021312.84K-7.45M-95.97%
Jun 30, 20207.77M6.47M499.78%
Jun 30, 20191.29M-2.34M-64.42%
Jun 30, 20183.64M2.84M354.63%
Jun 30, 2017800.46K625.41K357.27%
Jun 30, 2016175.05K--
Jun 30, 2015---
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---
Jun 30, 2011---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---
Jun 30, 2007---
Jun 30, 2006---
Jun 30, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Botanix Pharmaceuticals21.92M
Radiopharm Theranostics16.28M
Dimerix7.42M
Alterity Therapeutics6.64M
Amplia Therapeutics5.49M
Prescient Therapeutics4.27M
Arovella Therapeutics3.21M
Cynata Therapeutics1.69M
Revenue Rankings

Immutep News

More News